Related references
Note: Only part of the references are listed.Molecular and Kinetic Analyses of Circulating Tumor Cells as Predictive Markers of Treatment Response in Locally Advanced Rectal Cancer Patients
Bianca C. Troncarelli Flores et al.
CELLS (2019)
Circulating Exosomal miR-141-3p and miR-375 in Metastatic Progression of Rectal Cancer
Sebastian Meltzer et al.
TRANSLATIONAL ONCOLOGY (2019)
Assessment of a Watch-and-Wait Strategy for Rectal Cancer in Patients With a Complete Response After Neoadjuvant Therapy
J. Joshua Smith et al.
JAMA ONCOLOGY (2019)
Validation of miR-31-3p Expression to Predict Cetuximab Efficacy When Used as First-Line Treatment in RAS Wild-Type Metastatic Colorectal Cancer
Pierre Laurent-Puig et al.
CLINICAL CANCER RESEARCH (2019)
An experimental strategy unveiling exosomal microRNAs 486-5p, 181a-5p and 30d-5p from hypoxic tumour cells as circulating indicators of high-risk rectal cancer
Tonje Bjornetro et al.
JOURNAL OF EXTRACELLULAR VESICLES (2019)
miR-194 as predictive biomarker of responsiveness to neoadjuvant chemoradiotherapy in patients with locally advanced rectal adenocarcinoma
Edoardo D'Angelo et al.
JOURNAL OF CLINICAL PATHOLOGY (2018)
miR-519b-3p promotes responsiveness to preoperative chemoradiotherapy in rectal cancer patients by targeting ARID4B
Jialin Luo et al.
GENE (2018)
MicroRNA expression profiles identify biomarkers for predicting the response to chemoradiotherapy in rectal cancer
Binbin Du et al.
MOLECULAR MEDICINE REPORTS (2018)
Extensive screening of microRNA populations identifies hsa-miR-375 and hsa-miR-133a-3p as selective markers for human rectal and colon cancer
David Weber et al.
Oncotarget (2018)
MicroRNA molecular profiling identifies potential signaling pathways conferring resistance to chemoradiation in locally-advanced rectal adenocarcinoma
Cory Pettit et al.
Oncotarget (2018)
KRAS and BRAF mutations in circulating tumour DNA from locally advanced rectal cancer
Francesco Sclafani et al.
SCIENTIFIC REPORTS (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Metastatic pattern and new primary tumours after neoadjuvant therapy and surgery in rectal cancer
P. Frambach et al.
COLORECTAL DISEASE (2018)
miR-21, miR-99b and miR-375 combination as predictive response signature for preoperative chemoradiotherapy in rectal cancer
Marc Campayo et al.
PLOS ONE (2018)
Systematic review: Incidence, risk factors, survival and treatment of bone metastases from colorectal cancer
Troels Dreier Christensen et al.
JOURNAL OF BONE ONCOLOGY (2018)
The Role of MicroRNA Signature as Diagnostic Biomarkers in Different Clinical Stages of Colorectal Cancer
Sara Eslamizadeh et al.
CELL JOURNAL (2018)
Expression of Circulating miR-155, miR-21, miR-221, miR-30a, miR-34a and miR-29a: Comparison of Colonic and Rectal Cancer
Eniko Orosz et al.
IN VIVO (2018)
Watch-and-Wait as a Therapeutic Strategy in Rectal Cancer
Laurence Bernier et al.
CURRENT COLORECTAL CANCER REPORTS (2018)
Evaluation of several methodological challenges in circulating miRNA qPCR studies in patients with head and neck cancer
Dennis Poel et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2018)
Gene and MicroRNA Expression Are Predictive of Tumor Response in Rectal Adenocarcinoma Patients Treated With Preoperative Chemoradiotherapy
Caterina Millino et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2017)
The co-regulatory networks of tumor suppressor genes, oncogenes, and miRNAs in colorectal cancer
Martha L. Slattery et al.
GENES CHROMOSOMES & CANCER (2017)
Association between the expression of microRNAs and the response of patients with locally advanced rectal cancer to preoperative chemoradiotherapy
Anne Haahr Mellergaard Eriksen et al.
ONCOLOGY LETTERS (2017)
Identification of metastasis-associated microRNAs in serum from rectal cancer patients
Robin Mjelle et al.
ONCOTARGET (2017)
Serum miR-143 levels predict the pathological response to neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer
Yukiharu Hiyoshi et al.
ONCOTARGET (2017)
Stability of serum high-density lipoprotein-microRNAs for preanalytical conditions
Hiroaki Ishikawa et al.
ANNALS OF CLINICAL BIOCHEMISTRY (2017)
Stability of Circulating Blood-Based MicroRNAs - Pre-Analytic Methodological Considerations
Charlotte Glinge et al.
PLOS ONE (2017)
Development of a circulating miRNA assay to monitor tumor burden: From mouse to man
Alastair Greystoke et al.
MOLECULAR ONCOLOGY (2016)
Optimal Imaging Strategies for Rectal Cancer Staging and Ongoing Management
Svetlana Balyasnikova et al.
CURRENT TREATMENT OPTIONS IN ONCOLOGY (2016)
A Review of Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer
Yi Li et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2016)
Guidelines for the functional annotation of microRNAs using the Gene Ontology
Rachael P. Huntley et al.
RNA (2016)
Prognostic and predictive biomarkers in metastatic colorectal cancer anti-EGFR therapy
Cristiana Lo Nigro et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
miR-17-92a-1 cluster host gene (MIR17HG) evaluation and response to neoadjuvant chemoradiotherapy in rectal cancer
Chiara Molinari et al.
ONCOTARGETS AND THERAPY (2016)
Circulating tumor cells: A promising marker of predicting tumor response in rectal cancer patients receiving neoadjuvant chemo-radiation therapy
Wenjie Sun et al.
ONCOTARGET (2016)
Circulating serum microRNA-345 correlates with unfavorable pathological response to preoperative chemoradiotherapy in locally advanced rectal cancer
Jing Yu et al.
ONCOTARGET (2016)
Serum miR-125b is a non-invasive predictive biomarker of the pre-operative chemoradiotherapy responsiveness in patients with rectal adenocarcinoma
Edoardo D'Angelo et al.
ONCOTARGET (2016)
Stratification of Digestive Cancers with Different Pathological Features and Survival Outcomes by MicroRNA Expression
Senwei Tang et al.
SCIENTIFIC REPORTS (2016)
What Is the Ideal Tumor Regression Grading System in Rectal Cancer Patients after Preoperative Chemoradiotherapy?
Soo Hee Kim et al.
CANCER RESEARCH AND TREATMENT (2016)
Circulating biomarkers to monitor cancer progression and treatment
Suthee Rapisuwon et al.
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2016)
MicroRNA-31 Emerges as a Predictive Biomarker of Pathological Response and Outcome in Locally Advanced Rectal Cancer
Cristina Carames et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
MRI of Rectal Cancer: An Overview and Update on Recent Advances
Kartik S. Jhaveri et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2015)
Adenocarcinoma of the Rectum in Patients Under Age 40 Is Increasing: Impact of Signet-Ring Cell Histology
Patrick S. Tawadros et al.
DISEASES OF THE COLON & RECTUM (2015)
The comparison of miR-155 with computed tomography and computed tomography plus serum amyloid A protein in staging rectal cancer
Yun Yang et al.
JOURNAL OF SURGICAL RESEARCH (2015)
Preoperative Prediction of Lymph Node Status by Circulating Mir-18b and Mir-20a During Chemoradiotherapy in Patients with Rectal Cancer
Azadeh Azizian et al.
WORLD JOURNAL OF SURGERY (2015)
MicroRNA expression profiling identifies miR-31-5p/3p as associated with time to progression in wild-type RAS metastatic colorectal cancer treated with cetuximab
Jitka Mlcochova et al.
ONCOTARGET (2015)
Association of MicroRNA-31-5p with Clinical Efficacy of Anti-EGFR Therapy in Patients with Metastatic Colorectal Cancer
Hisayoshi Igarashi et al.
ANNALS OF SURGICAL ONCOLOGY (2015)
Overexpression of miR-21-5p as a predictive marker for complete tumor regression to neoadjuvant chemoradiotherapy in rectal cancer patients
Camila Miranda Lopes-Ramos et al.
BMC MEDICAL GENOMICS (2014)
Hsa-miR-31-3p Expression Is Linked to Progression-free Survival in Patients with KRAS Wild-type Metastatic Colorectal Cancer Treated with Anti-EGFR Therapy
Gilles Manceau et al.
CLINICAL CANCER RESEARCH (2014)
Regulation of microRNA biogenesis
Minju Ha et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2014)
miRBase: annotating high confidence microRNAs using deep sequencing data
Ana Kozomara et al.
NUCLEIC ACIDS RESEARCH (2014)
Multimodal imaging evaluation in staging of rectal cancer
Suk Hee Heo et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
miRNA expressions in rectal cancer as predictors of response to neoadjuvant chemoradiation therapy
Elrasheid A. H. Kheirelseid et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2013)
Pleiotropic actions of miR-21 highlight the critical role of deregulated stromal microRNAs during colorectal cancer progression
M. D. Bullock et al.
CELL DEATH & DISEASE (2013)
microRNA expression is able to predict response to chemoradiotherapy in rectal cancer
Masanori Hotchi et al.
MOLECULAR AND CLINICAL ONCOLOGY (2013)
The Rectal Cancer microRNAome - microRNA Expression in Rectal Cancer and Matched Normal Mucosa
Jochen Gaedcke et al.
CLINICAL CANCER RESEARCH (2012)
Identification of aberrantly expressed miRNAs in rectal cancer
Xinhua Li et al.
ONCOLOGY REPORTS (2012)
MicroRNA expression profile associated with response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer patients
Marek Svoboda et al.
RADIATION ONCOLOGY (2012)
MicroRNA profiling predicts survival in anti-EGFR treated chemorefractory metastatic colorectal cancer patients with wild-type KRAS and BRAF
Neda Mosakhani et al.
CANCER GENETICS (2012)
The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM
Stephen B. Edge et al.
ANNALS OF SURGICAL ONCOLOGY (2010)
MicroRNA: Biogenesis, Function and Role in Cancer
Leigh-Ann MacFarlane et al.
CURRENT GENOMICS (2010)
Many roads to maturity: microRNA biogenesis pathways and their regulation
Julia Winter et al.
NATURE CELL BIOLOGY (2009)
Share Paper
